The U.S. organ transplant system has approved its first national policy for normothermic regional perfusion, or NRP, and the decision should give pause to anyone who cares about the moral foundations of donation. The guidelines, approved by the OPTN board of directors on Nov. 6 and set to take effect Dec. 6, are meant to protect potential donors. Yet the central question remains unanswered: whether a person whose circulation has been restarted by a pump is still dead when surgeons begin to remove their organs.

The procedure is designed to keep organs healthy after a family has chosen to withdraw care. Dr. Raymond Lynch of the Health Resources & Services Administration argues that NRP could help address a shortage in which more than 109,000 Americans are waiting for a transplant and about 12 die each day. That goal is understandable. But the Dead Donor Rule exists precisely so that the urgency of need does not erode the boundary between death and retrieval. Dr. Lainie Friedman Ross of the University of Rochester says NRP violates that rule because it reverses the condition on which the donor was declared dead. Dr. Matthew DeCamp of the University of Colorado says the fundamental issues remain unresolved.

The new safeguards deserve scrutiny rather than applause. Lynch describes the added step of cutting or venting the blood vessels above the clamp as a second safeguard. Dr. Claire Morgan, who first reported cases in which blood appeared to reperfuse the brain, says that most surgeons already clamp and vent, and that she does not believe the policy adds much or any protection. If that is right, the guidelines standardize existing practice without answering the deeper objection.

The decision to implement this first phase on an emergency basis, before the public had a chance to weigh in, compounds the problem. Morgan has objected to that choice, and her concern is well placed. When a procedure touches the definition of death, the public has a legitimate interest in hearing the arguments before it becomes routine.

Organ shortages are real, and families waiting for transplants have every reason to want more options. But the answer to a shortage cannot be a policy that moves faster than the ethics. HRSA and the OPTN should pause broader adoption of NRP, open a public comment process, and resolve whether these donors are dead before the procedure becomes standard practice.